Ideal candidates include adults with type 2 diabetes, particularly those with obesity, cardiovascular disease, or inadequate control on other agents
Long-term Efficacy and Patient Adherence Sustaining the long-term efficacy of triple agonists relies on patient adherence and engagement
Sermorelin offers a short, natural-feeling pulse and a simple daily rhythm, which is why many people who prioritize sleep and recovery consider it
Many treatments are available via a monthly subscription, ensuring continuous access without the hassle of reordering
Sattar N, Lee MMY, Kristensen SL et al (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Rakipovski G, Rolin B, Nhr J, Klewe I, Frederiksen KS, Augustin R, et al